Alex Nikitine

Alex Nikitine

Partner
Dr. iur., LL.M., Avvocato

Sede

Zurigo

Contatto

Telefono diretto: +41 58 658 56 32
alex.nikitine@walderwyss.com

Curriculum Vitae

PDF download

Alex Nikitine is head of the Corporate/M&A team at Walder Wyss. His practice focuses on domestic and international M&A transactions, public tender offers, IPOs and other public (ECM/DCM) offerings, private equity and venture capital transactions, corporate governance and general corporate, stock exchange and capital markets laws. His experience for the last 15 years includes numerous transactions in these areas of expertise, in particular with companies in the Life Sciences, Banking or E-Commerce industry.

Alex Nikitine has been recommended by several international directories such as Chambers, IFLR1000 and The Legal 500 as a leading lawyer (by Chambers Global/Europe in both Corporate/M&A and Capital Markets). He is considered "knowledgeable and quick" and "likeable" and is being praised by his "out-of-the-box thinking" and "high level of client orientation" (Chambers, The Legal 500).

Alex Nikitine represents clients in proceedings before the SIX Swiss Exchange, the Swiss Takeover Board (UEK) and the Swiss financial market supervisory authority FINMA. He is a member of the board of examiners for the Swiss certified tax expert exams and a SIX Swiss Exchange recognised representative under art. 58a Listing Rules. He regularly publishes and speaks at conferences in his areas of expertise.

Alex Nikitine studied law at the University of Basel (lic. iur., 2000) and Harvard Law School (LL.M., 2004) and he received a doctorate (PhD; on Swiss and US securities laws) from the University of Zurich (Dr. iur., 2007). In 2009, he worked at Davis Polk & Wardwell LLP in New York, USA.

Alex Nikitine speaks German and English. He is registered with the Zurich Bar Registry and is admitted to practice in Switzerland as well as in the state of New York, USA.

Walder Wyss advised CRISPR Therapeutics (NASDAQ) on USD 280 Million Equity Issuance

ABB acquires Sevensense Robotics

Green Landscaping Group AB (publ) acquires Viva Gartenbau AG

Walder Wyss advised Nasdaq listed Altamira Therapeutics in its sale of majority stake in Altamira Medica

SkyCell AG - USD 57m financing round

Walder Wyss advises WEG S.A. as Swiss counsel in the acquisition of the industrial electric motors and generators business of the Regal Rexnord Corporation

IFLR 1000 Rankings - Walder Wyss as a top-performing law firm ranked

TP24 raises CHF 400m of additional funding from Barclays and M&G

UBS/CS Merger Completed

ITS Kanal Services AG acquires Restclean AG

Walder Wyss advised ANYbotics AG on CHF 45m Series B Round

DSM and Firmenich have completed their EUR 35 bn merger, becoming the leading creation and innovation partner in nutrition, beauty and well-being

ITS Kanal Services Ltd acquires Künzli Group

Swiss medtech company Distalmotion SA closes USD 150m Series F Financing Round

Axiom group acquires Swisslinx

Credit Suisse and UBS to Merge

Cinerius Financial Partners AG acquires a majority stake in Entrepreneur Partners AG

Porsche SE invests in ABB E-mobility’s CHF 325m Pre-IPO Private Placement

PostFinance Ventures, Migros and Serpentine Ventures invest in Properti AG

Bell Food Group invests in Vertical Farming Start-up YASAI

Hotel Saratz Pontresina has new owner

DSM and Firmenich to merge in EUR 42bn transaction, becoming the leading creation and innovation partner in nutrition, beauty and well-being

Zuger Kantonalbank (SIX: ZUGER) is acquiring Immofonds Asset Management AG

Westhive AG raises over CHF 6 million in series A financing round

Astorg acquires CordenPharma from ICIG

Swiss medtech company Distalmotion SA closes USD 90m Series E Financing Round

EH Group raises over CHF 5m Pre-Series A Financing

A.P. Moller Holding acquires Unilabs

Medimaps Group raises CHF 18.55 million

Infoniqa acquires Run My Accounts AG

Revalize aquires SpecPage AG

Scanmarket A/S acquires Symfact AG

Polyphor and EnBiotix sign merger agreement and agreement on sale of Murapavadin

Round di finanziamento di serie B per Sulzer & Schmid Laboratories AG

I fondi KLAR Partners acquisiscono ISS Servizio Canalizzazioni SA

Infoniqa acquisisce Sage Svizzera SA

Walder Wyss SA ha fornito consulenza ai bookrunner in relazione all’emissione di diritti di opzione del gruppo Swiss Steel

Walder Wyss fornisce consulenza a CRISPR sul programma di vendita di azioni “ATM” da USD 600 milioni

Round di finanziamento di serie B da CHF 7,8 milioni per 1plusX AG

Walder Wyss fornisce consulenza a CRISPR sul programma di vendita di azioni “ATM” da USD 350 milioni

Walder Wyss fornisce consulenza a ANYbotics AG relativamente a un round di finanziamento di serie A da 20 milioni di CHF

Round di finanziamento di serie B da 14 milioni di CHF di Memo Therapeutics

Walder Wyss fornisce consulenza a CRISPR su un’offerta di azioni da USD 520 milioni

Sunrise acquisisce il pioniere della web TV Wilmaa

Celanese Corporation (NYSE: CE) ha acquisito Elotex, la divisione delle polveri polimeriche ridisperdibili (RPP) di Nouryon

Walder Wyss ha fornito consulenza a Long State Investment Limited (LSI) per il suo investimento di circa CHF 31 milioni in WISeKey International Holding SA (WISeKey)

Walder Wyss fornisce consulenza a CRISPR in merito all’emissione di azioni per USD 310 milioni

Acquisto di Klinik Gais AG, kardiale Rehabilitation, Psychosomatik und Psychotherapie

Walder Wyss fornisce consulenza a Nestlé in merito alla vendita da CHF 10,2 miliardi della sua attività nel settore Skin Health

Round di finanziamento di USD 45 milioni di Beekeeper SA

Walder Wyss fornisce consulenza a CRISPR sul programma di vendita di azioni ATM da USD 200 milioni

SWISSTO12 raccoglie CHF 18,1 milioni

Sobi acquisisce la divisione di immunologia di NovImmunes con un’operazione da CHF 515 milioni

Round di finanziamento di serie A da 120 milioni di CHF di Tradeplus24, startup svizzera fintech

Round di finanziamento da CHF 15,5 milioni per la start-up svizzera Oculis SA

Il gigante tecnologico cinese Baidu investe nella start-up svizzera aiCTX

Walder Wyss ha fornito consulenza a 40 North per l’acquisizione e la successiva cessione di azioni in Clariant AG

IPO di Medartis alla SIX Swiss Exchange

La società svizzera Auris Médical Holding SA (Nasdaq) completa un “reverse share split” mediante una fusione di gruppo

Tamedia will die Medienvermarkterin Goldbach Gruppe (SIX: GBMN) übernehmen

Metall Zug (SIX: METN) übernimmt Mehrheit an der Haag-Streit Holding AG

AMEOS Gruppe erwirbt Seeklinik Brunnen

Walder Wyss berät Evolute Group AG bei der Durchführung der CHF 6 Mio. A Runde

Cembra Money Bank übernimmt SWISSBILLING SA, eine Anbieterin von Rechnungsfinanzierungen

Auris Medical's Public Equity Offering

Zug Estates CHF 100 Mio. Anleihe

Baloîse übernimmt Pax Anlage AG

Apax / Unilabs

Fairfax Financial to acquire Switzerland's Allied World for USD 4.9bn in cash and stock

Vollständige Integration der e-fon AG durch UPC Schweiz

Ascom verkauft Network Testing Division an InfoVista

Auris Medical lanciert ATM Offering

Swiss Life - CHF 600 Mio. Hybridanleihen

Internet TV Joint Venture Wilmaa & Teleboy

Bayer und CRISPR Therapeutics gründen Genome Editing Joint Venture

Management Buy-out Swisscanto/Zürcher Kantonalbank

Grenzüberschreitende Going Private Fusion der SHL Telemedicine Ltd. (SIX: SHLTN)

Computershare erwirbt SIX SAG AG

EUR 750 Mio. Hybridanleihe – Swiss Life

Life Invest Holding AG übernimmt Skandia Leben AG

Kliniken Valens übernimmt Rheinburg-Klinik

Evolva übernimmt Allylix mittels Aktientausch

IPO der Glarner Kantonalbank

L’Oréal erwirbt Decléor und Carita von Shiseido

Novadaq übernimmt Aïmago SA

HgCapital erwirbt 91.85% an P&I Personal & Informatik AG und lanciert öffentliches Übernahmeangebot

Swiss Life Holding AG platziert CHF 500 Millionen Wandelanleihe

IPO Cembra Money Bank

upc cablecom erwirbt 49%-Beteiligung an e-fon AG

Ammann-Gruppe veräussert Implenia-Anteile mittels Platzierungsverfahren

Verkauf der Klinik Villa im Park an Genolier Gruppe

Volvo Auto Bank Deutschland überträgt Schweizer Leasing- und Händlerfinanzierungs- geschäft an FCE Bank

Swiss Life Holding AG platziert zwei Senior Bonds über CHF 425 Mio.

Swiss Life closed CHF 800 million Loan Exchange Transaction

Swiss Life AG platziert eine Hybridanleihe über CHF 300 Mio.

Best Price Rule in Public Takeovers – MINOR Changes, MAJOR Effect

Different Requirements for Different Opting Out Clauses under Swiss Public Takeover Rules

Liquidation of unprofitable business by the target company as a permissible condition to a public offer

Liquidation of unprofitable business by the target company as a permissible condition to a public offer

Negotiations in M&A transactions - tips and tricks

Article 725 et seq. CO: (Il-)Liquidity, Capital Loss and Over-Indebtedness – New Duties for Swiss Boards

Commentary on Articles 64, 65 and 68 of the Financial Institutions Act (FinIA)

Entry 106115

Modifiche alle SIX Rules sulla pubblicità ad hoc in vigore dall’1 luglio 2021

IPO Readiness - Stolpersteine auf dem Weg zum Börsengang

Covid-19 Update: Emergency Loan Scheme for Start-ups

Guidelines on Shareholders’ Meetings under COVID-19 Ordinance 2

Adeguate le regole di dichiarazione nel quadro del diritto societario svizzero (cosiddette regole GAFI); applicazione di sanzioni penali

Der Erfolg unserer «Startuppers» ist die grösste Motivation

Börsengänge (IPO) 2017 / Schweiz

IPO Guide Schweiz (SIX Swiss Exchange) / Kotierungsanforderungen von SIX Swiss Exchange

Kommentar zum Finanzmarktinfrastrukturgesetz (FinfraG)

Management Buy-out - Vorvertragliche Aufklärungspflichten der Manager

Vermögensteuer auf Aktien von Startup-Unternehmen – neue Regeln im Kanton Zürich

Mergers & Acquisitions Practice Area Review

Changes to Swiss Rules on Disclosure of qualified Shareholdings

Kommentar zu Artikel 8-11, 30 VegüV

Venture capital investment in Switzerland: market and regulatory overview

Mergers & Acquisitions Practice Area Review

Adjustments to the Swiss Corporate Governance Framework

Cross-Border Equity Capital Markets – Switzerland

Debatte über neue Spielregeln durch die Minder-Initiative

Der unabhängige Stimmrechtsvertreter in der Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (VegüV): Überblick – herausgegriffene Fragen – Lösungsansätze

Umsetzung der «Abzocker-Initiative» – Die VegüV liegt vor.

Verletzung der Meldepflicht (Art. 20 BEHG) und der bankenrechtlichen Gewährspflicht/Entscheidbesprechung BVGE 2012/33

Draft Ordinance on Minder Initiative: No groundbreaking rules; interesting clarifications.

Venture capital investment in Switzerland: market and regulatory overview

Revision des Schweizer Börsenrechts und Corporate Governance Regeln

Minder-Initiative angenommen – Neue Corporate Governance Regeln für Schweizer Publikumsgesellschaften

Cross-Border Equity Capital Markets – Switzerland

SIX Swiss Exchange: Ja zum Schutz anwaltlicher Arbeitsprodukte im Untersuchungsverfahren der SIX und Ja zu hohen Geldbussen bei Verletzung des SIX Kotierungsreglements

Verwendung des Share Purchase Agreement in europäischen Jurisdiktionen: Schweiz

Fusion – Angebotspflicht – Opting-out

USA – Gesetzliche Regulierung der Management-Vergütung

Golden Handshakes, Golden Parachutes und ähnliche Vereinbarungen bei M&A-Transaktionen

Die aktienrechtliche Organverantwortlichkeit nach Art. 754 Abs. 1 OR als Folge unternehmerischer Fehlentscheide: Konzeption und Ausgestaltung der «Business Judgment Rule» im Gefüge der Corporate Governance

Riconoscimenti


Altri avvocati